The Minister for Health Jane Ruth Aceng has launched the randomized clinical trial for use of convalescent plasma for treatment of COVID-19 in Uganda.
The commencement of the trial will determine the efficacy of convalescent plasma in treating COVID-19.
A total of 162 COVID-19 convalescent plasma units have been collected.
This can be used to treat 65 patients.
The head Makerere University Lung Institute, Dr Bruce Kirenga says 186 recovered COVID-19 patients willingly consented to participate in the blood donation but only 162 qualified.
The donors came from all parts of Uganda except Karamoja region, where there was no COVID-19 infection at the time.
Convalescent refers to anyone recovering from a disease.
Plasma is the yellow, liquid part of blood that contains antibodies.
Antibodies are proteins made by the body in response to infections.
Convalescent plasma from patients who have already recovered from coronavirus disease 2019 (COVID-19) may contain antibodies against COVID-19.
Therefore it is therapy that uses blood from people who’ve recovered from an illness to help others recover.